NURS 6521N Week 9 Quiz : Advanced Pharmacology: Walden University
A patient with a recent diagnosis of chronic myelogenous leukemia (CML) is discussing treatment
options with his care team. What aspect of the patient's condition would contraindicate the use of
cyclophosphamide for the treatment of leukemia?
Response
Patients with severely compromised bone marrow functions cannot tolerate
Feedback:
treatment with cyclophosphamide. Diabetes, impaired renal function, and previous
nonadherence to treatment must be addressed when planning the patient's care, but these factors do
not necessarily contraindicate the use of cyclophosphamide.
Question 33
1 out of 1 points
A female patient is prescribed oprelvekin therapy to treat thrombocytopenia. Which of the following
should the nurse continuously monitor to determine the efficacy and duration of the oprelvekin
therapy?
Response
Oprelvekin stimulates the formation of platelets, so the nurse should regularly
Feedback:
monitor the platelet count to determine the duration of the therapy. The
therapy should be continued until the postnadir platelet count is at least 50,000 cells/mm3. The
oprelvekin therapy is effective if the platelet count rises to a normal range without severe bleeding.
Fluid retention, weight gain, and arrhythmias are major adverse effects of oprelvekin therapy and
would not be a measure of the efficacy and duration of the therapy.
Question 34
1 out of 1 points
A nurse is to use a single-dose 1 mL vial to administer 0.5 mL of epoetin alfa to a 39 -year- old woman
who is being treated for chemotherapy-induced anemia. Which of the following will the nurse do with
the unused portion of the drug?
Response
The single-dose 1-mL vial does not have preservatives. In order to prevent
Feedback:
contamination, the nurse will discard the unused portion of the drug. A 2-mL vial does have
preservatives and would be stored at 2°C to 8°C to be used
Distribution of this document is illegal
again. The 2-mL vial should be discarded 21 days after initial entry to prevent use of a possibly
contaminated product.
Question 35
1 out of 1 points
pg. 1 Question 1
, A 45-year-old woman with acute leukemia is going to begin chemotherapy with vincristine. The nurse is
aware that vincristine must always be administered
A. at a rapid infusion rate.
B. at a slow infusion rate.
C. through a central line.
D. through an IV line primed with vincristine.
1 points
Question 2
A 62-year-old patient taking tamoxifen exhibits increased bone and tumor pain along with a local
disease flare. The nurse interprets this as an indication of which of the following?
A.
A hypersensitivity reaction
B.
Cardiomyopathy
C.
Nephrotoxic effects of tamoxifen
D.
The tumor responding to treatment
1 points
Question 3
A middle-aged patient has received a diagnosis of GI stromal tumor following an extensive diagnostic
workup. Imatinib has been recommended as a component of the patient's drug regimen. What patient
education should the nurse provide to this patient?
A.
“If you experience significant nausea after taking a dose, stop taking the drug and schedule an
appointment at the clinic.” B.
“Try to keep your PICC line dressing as dry as possible at all times.”
C.
“It's important that you let us know if you develop any significant swelling or puffiness.”
D.
“You'll likely experience a lot of dry mouth while you're taking this drug, so it's helpful to chew ice
chips.”
1 points
pg. 2
Question 4
, A nurse has completed a medication reconciliation of a patient who has been admitted fo llowing a
motor vehicle accident. Among the many drugs that the patient has received in the previous year is
rituximab. The nurse would be justified in suspecting the patient may have received treatment for which
of the following diseases?
A.
Malignant melanoma
B.
Non-Hodgkin's lymphoma
C.
Nonsmall cell lung cancer
D.
Renal cell carcinoma
1 points
Question 5
A nurse has been assigned to a 55-year-old woman who has a malignant brain tumor. The patient is
receiving her first dose of carmustine. It will be critical for the nurse to observe for which of the
following?
A.
Inability to drink fluids for 6 hours
B.
Nausea and vomiting
C.
Reddish urine
D.
Respiratory difficulty
1 points
Question 6
A nurse is caring for a 64-year-old female patient who is receiving IV heparin and reports bleeding from
her gums. The nurse checks the patient's laboratory test results and finds that she has a very high aPTT.
The nurse anticipates that which of the following drugs may be ordered?
A. Alteplase
B. Coumadin
C. Ticlopidine
pg. 3 D.
Protamine sulfate
A patient with a recent diagnosis of chronic myelogenous leukemia (CML) is discussing treatment
options with his care team. What aspect of the patient's condition would contraindicate the use of
cyclophosphamide for the treatment of leukemia?
Response
Patients with severely compromised bone marrow functions cannot tolerate
Feedback:
treatment with cyclophosphamide. Diabetes, impaired renal function, and previous
nonadherence to treatment must be addressed when planning the patient's care, but these factors do
not necessarily contraindicate the use of cyclophosphamide.
Question 33
1 out of 1 points
A female patient is prescribed oprelvekin therapy to treat thrombocytopenia. Which of the following
should the nurse continuously monitor to determine the efficacy and duration of the oprelvekin
therapy?
Response
Oprelvekin stimulates the formation of platelets, so the nurse should regularly
Feedback:
monitor the platelet count to determine the duration of the therapy. The
therapy should be continued until the postnadir platelet count is at least 50,000 cells/mm3. The
oprelvekin therapy is effective if the platelet count rises to a normal range without severe bleeding.
Fluid retention, weight gain, and arrhythmias are major adverse effects of oprelvekin therapy and
would not be a measure of the efficacy and duration of the therapy.
Question 34
1 out of 1 points
A nurse is to use a single-dose 1 mL vial to administer 0.5 mL of epoetin alfa to a 39 -year- old woman
who is being treated for chemotherapy-induced anemia. Which of the following will the nurse do with
the unused portion of the drug?
Response
The single-dose 1-mL vial does not have preservatives. In order to prevent
Feedback:
contamination, the nurse will discard the unused portion of the drug. A 2-mL vial does have
preservatives and would be stored at 2°C to 8°C to be used
Distribution of this document is illegal
again. The 2-mL vial should be discarded 21 days after initial entry to prevent use of a possibly
contaminated product.
Question 35
1 out of 1 points
pg. 1 Question 1
, A 45-year-old woman with acute leukemia is going to begin chemotherapy with vincristine. The nurse is
aware that vincristine must always be administered
A. at a rapid infusion rate.
B. at a slow infusion rate.
C. through a central line.
D. through an IV line primed with vincristine.
1 points
Question 2
A 62-year-old patient taking tamoxifen exhibits increased bone and tumor pain along with a local
disease flare. The nurse interprets this as an indication of which of the following?
A.
A hypersensitivity reaction
B.
Cardiomyopathy
C.
Nephrotoxic effects of tamoxifen
D.
The tumor responding to treatment
1 points
Question 3
A middle-aged patient has received a diagnosis of GI stromal tumor following an extensive diagnostic
workup. Imatinib has been recommended as a component of the patient's drug regimen. What patient
education should the nurse provide to this patient?
A.
“If you experience significant nausea after taking a dose, stop taking the drug and schedule an
appointment at the clinic.” B.
“Try to keep your PICC line dressing as dry as possible at all times.”
C.
“It's important that you let us know if you develop any significant swelling or puffiness.”
D.
“You'll likely experience a lot of dry mouth while you're taking this drug, so it's helpful to chew ice
chips.”
1 points
pg. 2
Question 4
, A nurse has completed a medication reconciliation of a patient who has been admitted fo llowing a
motor vehicle accident. Among the many drugs that the patient has received in the previous year is
rituximab. The nurse would be justified in suspecting the patient may have received treatment for which
of the following diseases?
A.
Malignant melanoma
B.
Non-Hodgkin's lymphoma
C.
Nonsmall cell lung cancer
D.
Renal cell carcinoma
1 points
Question 5
A nurse has been assigned to a 55-year-old woman who has a malignant brain tumor. The patient is
receiving her first dose of carmustine. It will be critical for the nurse to observe for which of the
following?
A.
Inability to drink fluids for 6 hours
B.
Nausea and vomiting
C.
Reddish urine
D.
Respiratory difficulty
1 points
Question 6
A nurse is caring for a 64-year-old female patient who is receiving IV heparin and reports bleeding from
her gums. The nurse checks the patient's laboratory test results and finds that she has a very high aPTT.
The nurse anticipates that which of the following drugs may be ordered?
A. Alteplase
B. Coumadin
C. Ticlopidine
pg. 3 D.
Protamine sulfate
